Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Life and Health Insurance Industry Analysis

UpdatedJul 08, 2026
DataAggregated Company Financials
Companies5
  • 7D6.3%
  • 3M19.2%
  • 1Y69.3%
  • YTDn/a

All of the companies in the Life and Health Insurance industry have been up over the last week, with the industry up 6.3%. In the last 12 months, the industry was up 69%. Looking forward, earnings are forecast to grow by 9.3% annually.

Industry Valuation and Performance

Has the Japanese Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 08 Jul 2026JP¥17.4tJP¥27.6tJP¥1.1t17.1x15.4x0.6x
Fri, 05 Jun 2026JP¥15.4tJP¥27.6tJP¥1.1t14.2x13.7x0.6x
Sun, 03 May 2026JP¥13.4tJP¥26.5tJP¥1.1t13.2x12.3x0.5x
Tue, 31 Mar 2026JP¥13.8tJP¥26.5tJP¥1.1t13.8x12.7x0.5x
Thu, 26 Feb 2026JP¥15.0tJP¥26.5tJP¥1.1t15.3x13.7x0.6x
Sat, 24 Jan 2026JP¥13.8tJP¥26.4tJP¥1.1t13.8x12.9x0.5x
Mon, 22 Dec 2025JP¥12.9tJP¥26.4tJP¥1.1t12.2x12x0.5x
Wed, 19 Nov 2025JP¥11.7tJP¥26.4tJP¥1.1t10.9x11x0.4x
Fri, 17 Oct 2025JP¥11.5tJP¥26.4tJP¥974.1b12x11.8x0.4x
Sun, 14 Sep 2025JP¥12.7tJP¥26.4tJP¥974.1b13.4x13x0.5x
Tue, 12 Aug 2025JP¥12.4tJP¥26.4tJP¥973.8b13.1x12.8x0.5x
Thu, 10 Jul 2025JP¥11.0tJP¥27.0tJP¥1.1t10.8x10.4x0.4x
Sat, 07 Jun 2025JP¥11.3tJP¥28.0tJP¥1.1t10.8x10.7x0.4x
Mon, 05 May 2025JP¥10.4tJP¥28.8tJP¥1.0t9.8x10.1x0.4x
Wed, 02 Apr 2025JP¥11.6tJP¥28.8tJP¥1.0t10.7x11.2x0.4x
Fri, 28 Feb 2025JP¥11.9tJP¥28.8tJP¥1.0t10.7x11.5x0.4x
Sun, 26 Jan 2025JP¥11.3tJP¥28.9tJP¥911.2b12.3x12.4x0.4x
Tue, 24 Dec 2024JP¥11.2tJP¥28.9tJP¥911.2b12.2x12.3x0.4x
Thu, 21 Nov 2024JP¥10.7tJP¥28.2tJP¥955.2b13x11.2x0.4x
Sat, 19 Oct 2024JP¥10.5tJP¥28.2tJP¥947.4b11.8x11.1x0.4x
Mon, 16 Sep 2024JP¥9.9tJP¥28.2tJP¥947.4b11.3x10.5x0.4x
Wed, 14 Aug 2024JP¥10.3tJP¥28.2tJP¥947.3b12.1x10.9x0.4x
Fri, 12 Jul 2024JP¥12.7tJP¥27.8tJP¥781.0b16.2x16.2x0.5x
Sun, 09 Jun 2024JP¥11.2tJP¥27.7tJP¥781.0b14.6x14.4x0.4x
Tue, 07 May 2024JP¥10.5tJP¥25.8tJP¥732.3b13.7x14.4x0.4x
Thu, 04 Apr 2024JP¥10.9tJP¥25.8tJP¥732.3b14x14.9x0.4x
Sat, 02 Mar 2024JP¥10.8tJP¥25.8tJP¥732.3b14.2x14.7x0.4x
Mon, 29 Jan 2024JP¥10.0tJP¥26.0tJP¥746.0b13.3x13.4x0.4x
Wed, 27 Dec 2023JP¥9.3tJP¥26.0tJP¥746.0b12x12.4x0.4x
Fri, 24 Nov 2023JP¥9.8tJP¥25.9tJP¥742.1b12.6x13.2x0.4x
Sun, 22 Oct 2023JP¥9.8tJP¥26.2tJP¥533.3b14x18.4x0.4x
Tue, 19 Sep 2023JP¥9.7tJP¥26.2tJP¥533.3b13.7x18.2x0.4x
Thu, 17 Aug 2023JP¥8.3tJP¥26.3tJP¥523.2b11.8x15.8x0.3x
Sat, 15 Jul 2023JP¥8.2tJP¥25.7tJP¥583.7b8.3x14.1x0.3x
Price to Earnings Ratio

14.1x


Total Market Cap: JP¥8.2tTotal Earnings: JP¥583.7bTotal Revenue: JP¥25.7tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Life and Health Insurance Industry Price to Earnings3Y Average 13.1x202420252026
Current Industry PE
  • Investors are optimistic on the Japanese Life and Health Insurance industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 15.4x which is higher than its 3-year average PE of 13.1x.
  • The industry is trading close to its 3-year average PS ratio of 0.42x.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 2.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Japanese Life and Health Insurance compare with similar industries?

JP Market1.05%
Financials6.81%
Insurance6.68%
Life and Health Insurance6.34%
Property and Casualty Insurance6.92%
Insurance Brokers2.45%
General Insurance-0.34%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6178 Japan Post HoldingsJP¥2.37k9.3%
+JP¥550.9b		75.6%PE17.3x
8750 Daiichi Life GroupJP¥1.86k4.1%
+JP¥262.9b		73.8%PE15.4x
7181 Japan Post InsuranceJP¥1.65k8.4%
+JP¥133.7b		44.1%PE10.3x
8795 T&D HoldingsJP¥4.93k2.5%
+JP¥56.9b		56.0%PE17x
7157 Lifenet InsuranceJP¥1.75k15.6%
+JP¥19.0b		-17.1%PE17.4x

Latest News

7157
JP¥1,746.00
Lifenet Insurance
7D
15.6%
1Y
-17.1%
7181
JP¥1,646.00
Japan Post Insurance
7D
8.4%
1Y
44.1%
Narrative Update • Jul 02

7181: Executive Transition And Dividend Policy Will Support Future Share Upside

Analysts have reduced their fair value estimate for Japan Post Insurance from ¥2,099.98 to ¥2,000.00 as they incorporate updated assumptions for revenue growth, profit margins and a higher forward P/E multiple. What’s in the News for Japan Post Insurance Japan Post Insurance scheduled a board meeting on May 15, 2026 to consider a notice regarding a change in Representative Executive Officer.
8795
JP¥4,934.00
T&D Holdings
7D
2.5%
1Y
56.0%
Narrative Update • Jul 02

8795: Buybacks And Dividend Hikes Will Mask Weaker Revenue Outlook

The analyst price target for T&D Holdings has been lifted from ¥3,870 to approximately ¥3,956, with analysts pointing to revised assumptions that combine lower revenue growth expectations with a higher profit margin forecast and a slightly richer future P/E multiple. What’s in the News for T&D Holdings T&D Holdings completed a share repurchase tranche from June 4, 2026 to June 30, 2026, buying 1,315,400 shares (0.27% of shares) for ¥6,261.84 million under its existing buyback program.
6178
JP¥2,370.00
Japan Post Holdings
7D
9.3%
1Y
75.6%
8750
JP¥1,864.00
Daiichi Life Group
7D
4.1%
1Y
73.8%
Narrative Update • Jun 24

8750: Higher Dividends And Stock Compensation Shift Will Support Balanced Outlook

Analysts have raised their price target for Daiichi Life Group from ¥1,630 to ¥1,781, citing updated assumptions that incorporate an expected revenue growth rate of 3.5%, along with a slightly revised profit margin and forward P/E framework. What’s in the News for Daiichi Life Group Daiichi Life Group plans to issue new restricted and performance-linked shares to directors and executives across the group, aiming to align management incentives with shareholder interests while keeping dilution limited.